Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2017 Mar 14;114(13):3403–3408. doi: 10.1073/pnas.1620881114

Distinct recognition of complement iC3b by integrins αXβ2 and αMβ2

Shutong Xu a,1, Jianchuan Wang b,1, Jia-Huai Wang a,c,2, Timothy A Springer b,2
PMCID: PMC5380021  PMID: 28292891

Significance

Complement is deposited on foreign antigens and particles and marks them for recognition by immune cells and removal by phagocytes. Immune cells have two homologous integrins, αXβ2 and αMβ2, that recognize the complement fragment iC3b. Although it might have been suspected that these integrins would bind to the same site on iC3b, direct comparisons here show they do not. Using negative stain electron microscopy and purified integrin fragments and iC3b, we show that αXβ2 binds to two distinct sites on iC3b. A single αMβ2 integrin binds to two different sites on iC3b, each of which is distinct from those to which αXβ2 binds. Our findings reveal remarkable diversity among integrins that recognize complement and suggest possible cooperative responses.

Abstract

Recognition by the leukocyte integrins αXβ2 and αMβ2 of complement iC3b-opsonized targets is essential for effector functions including phagocytosis. The integrin-binding sites on iC3b remain incompletely characterized. Here, we describe negative-stain electron microscopy and biochemical studies of αXβ2 and αMβ2 in complex with iC3b. Despite high homology, the two integrins bind iC3b at multiple distinct sites. αXβ2 uses the αX αI domain to bind iC3b on its C3c moiety at one of two sites: a major site at the interface between macroglobulin (MG) 3 and MG4 domains, and a less frequently used site near the C345C domain. In contrast, αMβ2 uses its αI domain to bind iC3b at the thioester domain and simultaneously interacts through a region near the αM β-propeller and β2 βI domain with a region of the C3c moiety near the C345C domain. Remarkably, there is no overlap between the primary binding site of αXβ2 and the binding site of αMβ2 on iC3b. Distinctive binding sites on iC3b by integrins αXβ2 and αMβ2 may be biologically beneficial for leukocytes to more efficiently capture opsonized pathogens and to avoid subversion by pathogen factors.


Activation of mammalian complement is critical for the clearance of pathogens and altered host cells, whereas excessive activation results in tissue damage (1). Complement activation can be initiated by three distinct pathways with proteolytic cleavage of complement component C3 as the pivotal step in each pathway. C3 is cleaved to C3b by C3 convertases. C3b participates in some C3 convertases to amplify C3 cleavage; however, further cleavage of C3b to iC3b inactivates convertase activity. In turn, iC3b can be digested to yield C3c plus C3dg, and C3dg can be further cleaved to C3d (2) (Fig. 1A). Conversion of C3 to C3b exposes the otherwise buried reactive thioester bond in the thioester domain (TED) and enables it to covalently attach to hydroxyl and amino groups on pathogenic, immunogenic, and apoptotic cell surfaces (3). Opsonic fragments of C3 covalently bound through the TED, i.e., C3b, iC3b, and C3dg/C3d serve as ligands for five distinct complement receptors (CRs). Each CR has been characterized for its preference for specific C3 opsonic fragments. CR type 3 (CR3, also known as CD11b/CD18, Mac-1, or integrin αMβ2) and CR type 4 (CR4, also known as CD11c/CD18, p150, 95, or integrin αXβ2) specifically recognize iC3b as shown by selective rosette formation with erythrocytes opsonized with iC3b but not C3b or C3d (46), and specific isolation from cells by affinity chromatography on iC3b-Sepharose beads (7). However, at high concentrations on opsonized cells, C3d and C3dg can show reactivity with CR3 (8, 9).

Fig. 1.

Fig. 1.

Integrins, iC3b, and negative-stain EM of αX I domain and iC3b complexes. (A) Schematic of iC3b. (B) Schematic of domain organization and conformational states of αI-integrins αXβ2 and αMβ2. (C) Superdex 200 size exclusion chromatography profiles of iC3b in presence or absence of the αX αI F273S/F300A mutant in presence of 2 mM Mg2+. (D) Better resolved class averages of αX αI and iC3b complexes. (Scale bar: 10 nm.) Schematic interpretations of classes are shown to the right.

αXβ2 and αMβ2 are heterodimeric proteins belonging to the β2 integrin subfamily. They are expressed on myeloid cells including neutrophil granulocytes, monocytes, macrophages, and also on activated lymphocytes and lymphoid natural killer cells (1012). αXβ2 and αMβ2 are essential for recognition and phagocytosis of pathogens and immune complexes in vivo (13). Deficiency of αXβ2 and αMβ2 in leukocyte adhesion deficiency results in recurring bacterial infections (14) and deficiency of αMβ2 alters susceptibility to injury from immune complexes (15). The β2-associated α subunits all contain an inserted domain (αI domain), which adopts a Rossmann fold with a metal ion-dependent adhesion site (MIDAS) at the ligand-binding site (Fig. 1B) (16).

The αI domain of αXβ2 and αMβ2 plays a key role in recognition of iC3b by both integrins; however, alternative recognition modes have also been suggested. Mutagenesis and antibody blocking studies on αXβ2 and αMβ2 showed that the αI domain was required for binding to iC3b (6, 17, 18). More recently, electron microscopy (EM) studies with the αXβ2 ectodomain revealed binding solely through its αI domain to a site at the interface between the macroglobulin (MG) 3 and MG4 domains on the C3c moiety of iC3b (Fig. 1A) (19). However, stoichiometry suggests multiple binding sites for the αX αI domain in iC3b (20). Because of the high similarity between αXβ2 and αMβ2, it was expected that αMβ2 would bind to the same site on iC3b as αXβ2. It was surprising then when a crystal structure of a complex between the αM αI domain and TED (C3d) revealed a specific complex between them (21). As the authors pointed out, binding of the αM αI domain alone to TED could not explain the specificity of αMβ2 for binding to iC3b and not to C3d (21). Moreover, the αM subunit β-propeller domain and the β2 subunit inserted domain (βI) (Fig. 1B) have been suggested to additionally contribute to iC3b binding (2224). Both αMβ2 and αXβ2 recognize a variety of unrelated ligands and proteolyzed or denatured proteins (25); given this broad specificity, αXβ2 has been termed a “danger receptor” (26). Furthermore, the isolated αM αI domain has been crystallized in the open conformation bound to a neighboring αI domain in a ligand-mimetic lattice contact (27). Thus, it was interesting to determine whether the αM αI domain complex with the TED domain in crystals (21) could be extended to larger integrin and complement fragments and whether additional contacts might be found. These findings also suggested the importance of further comparisons between αMβ2 and αXβ2, particularly with integrin fragments complementary to those previously used in structural studies, i.e., the ectodomain in the case of αXβ2 (19) and the αI domain in the case of αMβ2 (21).

Using negative-stain EM with the αX αI domain and the αMβ2 headpiece here, we have shown that αXβ2 and αMβ2 bind to different regions of iC3b. Distinct recognition modes toward iC3b by two closely related β2 integrins reveal surprising diversity that might be important for complement recognition in the context of the quite different surfaces or antigens on which complement can be deposited and enable cooperative rather than competitive functions for αXβ2 and αMβ2.

Results

Interaction of αXβ2 with iC3b.

To stabilize the high-affinity state of the isolated αX αI domain (αX residues E130-G319), we introduced mutations F273S and F300A. Homologous mutations F265S and F292A had been found by random mutagenesis followed by directed evolution to increase the affinity of the αL αI domain and stabilize its open conformation (28). The corresponding residues in αX have identical structural environments, which suggested that their mutation should similarly stabilize the open, high-affinity conformation. Indeed, the F273S/F300A αX αI domain, used in all studies below, formed a complex with iC3b that was stable to gel filtration in buffer containing 2 mM Mg2+ and eluted earlier than iC3b alone (Fig. 1C). In contrast, the wild-type αXβ2 ectodomain required not only the activating metal ion Mn2+, but also Fabs that stabilize the open integrin headpiece conformation (Fig. 1B), to form complexes with iC3b that were stable to gel filtration (19).

The isolated αX αI complex with iC3b was subjected to negative-stain EM with multivariate K-means classification and multireference alignment of >5,000 particles into 50 class averages (Fig. S1). Class averages were visualized corresponding to both the αX αI domain bound to iC3b (Fig. 1D, 1–4) and iC3b alone (Fig. 1D, 5–8). The αX αI domain bound to the key ring moiety formed by MG domains 1–8 of iC3b (Fig. 1 A and D). The key ring moiety can be oriented both (i) by its weaker density on the side with only MG3 and MG4 compared with the thicker density on the side where MG1 and MG2 stack atop MG5 and MG6 and (ii) by the slant of the C345C knob toward the thick side (Fig. 1A). This orientation confirmed binding of the αI domain to MG3 and MG4 near their interface (Fig. 1D, 1–4 and schematics).

Fig. S1.

Fig. S1.

Complete set of class averages of αX αI and iC3b complex (6,202 particles). Classes are ranked from most to least populous from left to right and then from top to bottom.

In conversion from C3b to iC3b, factor I cleaves the CUB domain in its C-terminal linkage to TED. Cleavage leaves TED tethered to the C3c moiety through its N-terminal linkage. In agreement with previous results (29), we found that the TED is flexibly tethered to the C3c moiety in iC3b, as shown by its appearance in different orientations and distances relative to the C3c moiety (Fig. 1D, 1, 2, 5, and 6) and its lack of defined orientation (absence of density) in other class averages (Fig. 1D, 3, 4, 7, and 8). The TED (296 residues) was clearly distinguished by its stronger density from the smaller αI domain (190 residues) (Fig. 1D).

Interaction of αXβ2 with C3c.

Further cleavage by factor I of iC3b in the CUB domain separates TED (C3dg) from C3c. We prepared αX αI domain complexes with C3c in Mg2+ by gel filtration (Fig. 2A) and characterized them by EM (Fig. 2B and Fig. S2A) using the same methods as described above for iC3b. Although some particles showed C3c alone (Fig. 2B, 1 and 2), most (30 classes, corresponding to 68% of particles) showed αI bound near the MG3-MG4 interface on the MG key ring (Fig. 2B, 3–8). Strikingly, at least 8 of 50 class averages showed an additional density for αI near the C345C knob (Fig. 2B, 5–8).

Fig. 2.

Fig. 2.

Negative-stain EM of αX αI domain complexes with C3c and comparison with αXβ2 ectodomain complexes with C3c and iC3b. (A) Superdex 200 size exclusion chromatography profiles of C3c, the αX αI F273S/F300A mutant, or their mixture in presence of 2 mM Mg2+. (B) Better resolved class averages of αX αI and C3c complexes. Schematic interpretations of the averages are shown to the right. (CE) Complexes (2:1) containing two integrin αXβ2 ectodomains bound to C3c (C) or iC3b (D) or for comparison 1:1 αXβ2:C3c class averages (E) (19). The 2:1 complexes were identified among published 1:1 complexes (19) as described in Results. To confirm the position of the C3c or the C3c moiety of iC3b in the class averages (Top), class averages were masked (Middle) and cross-correlated with a C3c crystal structure (Bottom) with cross-correlation score and C3c ribbon cartoon shown below. (Scale bars: 10 nm.) (F) Schematic of 2:1 complexes. Three Fabs bound to αXβ2 to stabilize its extended-open conformation are shown. E reproduced from ref. 19.

Fig. S2.

Fig. S2.

EM of αX αI and αXβ2 ectodomain complexes with C3c. (A) Complete set of class averages of αX αI and C3c complex (5,042 particles) as described in Fig. S1. (B) An EM field containing αXβ2-three Fabs–C3c complexes. Two αXβ2-C3c (2:1) complex-like particles are circled in red.

In five class averages (9.5% of particles), the second αI domain appeared on the thick side of the MG key ring (Fig. 2B, 5 and 6), whereas in others (3.3% of particles), it appeared on the opposite side of the C345C knob nearer the thin side of the MG key ring (Fig. 2B, 7 and 8). The differing orientations might reflect binding to the flexible remnants of the cleaved CUB domain, which localize near the C345C knob, and/or may reflect a 3D orientation of αI out of the C3c plane visualized in Fig. 2B and the tendency of particles to lie flat on EM substrates.

Having found two binding sites for the isolated αX αI domain in the C3c moiety, we then asked whether two binding sites could also be found with the intact αXβ2 ectodomain. We reexamined grids from a published study (19) on C3c complexes formed with the αXβ2 ectodomain stabilized in the high-affinity state with three Fab fragments. We found in the same fields from which 4,387 1:1 αXβ2:C3c particles had been picked 121 putative 2:1 particles that were classified into two classes (Fig. 2C and Fig. S2B). Indeed, both class averages revealed 2:1 αXβ2 ectodomain-Fab:C3c complexes. The orientations were similar in the two classes (Fig. 2C, diagrammed in Fig. 2F), although density was clearest in the most populous average (Fig. 2C, 1). Our domain assignments were confirmed by masking all segments except C3c, and cross-correlation with the C3c crystal structure (Fig. 2C, Middle and Bottom). The cross-correlation scores were excellent and were comparable to those using the C3c moiety from 1:1 complexes (Fig. 2E, Middle and Bottom). The orientation of the two integrins in the class averages is readily assigned based on densities for the head containing the αI, β-propeller, and βI domains, and weaker densities for the α- and β-subunit legs. The two integrins orient with their β-subunits facing toward one another as shown by the stronger density of the large β-propeller domain, which marks the α-subunit side of the head, and m24 Fab, which binds to the βI domain and marks the β-subunit side of the head (Fig. 2 C and F). Importantly, these landmarks, and the densities for the two αI domains, confirm that the αI domain in one integrin binds near the MG3-MG4 interface in the MG key ring and that the αI domain in the other integrin binds near the C345C knob, exactly as described above for isolated αX αI domains.

We then asked whether 2:1 complexes might be present within αXβ2 complexes with iC3b (19). In the same fields from which 5,134 1:1 complexes had been subjected to class averaging (19), we found 161 putative 2:1 complexes that were subjected to classification and averaging into two classes (Fig. 2D). The most populous class average showed the same two αI domain sites on iC3b as seen with C3c, with one binding site near the MG3-MG4 interface and the other near the C345C knob (Fig. 2D, 1). The second class average was less clear, although density for m24 Fab bound to each integrin suggested a similar integrin orientation as in the other class average.

Recognition of iC3b but Not C3c by αMβ2.

A headpiece fragment of αMβ2 in 1 mM Mn2+ and 0.2 mM Ca2+ formed complexes with iC3b that were stable to gel filtration as shown by elution of the complex earlier than iC3b alone or the αMβ2 headpiece monomer (Fig. 3 A and C). EM class averages showed that the αMβ2 headpiece bound through its αI domain to the iC3b TED (Fig. 3D and Fig. S3A). The position of the TED with respect to the C3c moiety of iC3b varied much less in complexes with αMβ2 than in complexes with the αX αI domain or in iC3b alone (Fig. 1D) (19, 29). Furthermore, the C3c moiety adopted similar, nonrandom orientations with respect to the integrin, with its C345C knob close to the β-propeller and βI domains in the integrin head (Fig. 3D). In some class averages, the knob approached the head closely (Fig. 3D, 5 and 6). The nonrandom orientation of the C3c moiety and close approach of its knob to the integrin strongly suggest a second three-dimensional contact between the integrin and iC3b that is less stable than the αI-TED contact and is susceptible to disruption when complexes adsorb to the grid and become largely planar.

Fig. 3.

Fig. 3.

Negative-stain EM of αMβ2 headpiece complexes. (AC) Superdex 200 size exclusion chromatography profiles of complexes and individual components in Mn2+ with iC3b (A), C3c (B), or the αMβ2 headpiece alone in Mg2+ or Mn2+ (C). (D and E) Better resolved class averages of the αMβ2 headpiece complex with iC3b (D) and αMβ2 headpiece homodimer complexes in Mn2+ (E). To figure out whether the αMβ2 headpiece is in open or closed conformation, class averages were masked (row 2) and cross-correlated with a modeled open form αxβ2 headpiece (row 3) or a crystal structure of αXβ2 headpiece in closed conformation (PDB ID code 4NEH) (row 4). The cross-correlation scores are labeled. The schematic interpretations of the class averages are shown below. (Scale bar: 10 nm.)

Fig. S3.

Fig. S3.

EM of high molecular weight, putative complex fractions from gel filtration in Mn2+. Complete sets of class averages are shown for αMβ2 headpiece with iC3b (A, 4,883 particles), αMβ2 headpiece with C3c (B, 4,206 particles), and αMβ2 headpiece alone (C, 2,842 particles). Classes are ranked by population as described in Fig. S1.

In contrast to iC3b, C3c failed to complex with the αMβ2 headpiece (Fig. 3B). An early eluting peak was present in samples containing C3c and αMβ2 or αMβ2 alone, but not in C3c alone (Fig. 3B). This peak contained no αMβ2–C3c complex but did contain an αMβ2 headpiece dimer (Fig. S3B) as described in Dimerization of the αMβ2 Headpiece.

Ligand binding by other αI domain-containing integrins has been associated with headpiece opening, as visualized in EM by swing-out of the hybrid domain (Fig. 1B). To determine whether the headpiece was open or closed in αMβ2 bound to iC3b, we cross-correlated it to crystal structures or models of the closed and open αXβ2 headpiece. Better correlation to the open headpiece revealed that the αMβ2 headpiece is open when bound to iC3b (Fig. 3D, Bottom). Moreover, cross-correlation showed that the headpiece oriented with its β-subunit adjacent to the C3c moiety in all class averages. This nonrandom orientation of the αMβ2 headpiece provided further evidence for a specific interaction of its β-propeller and βI domain region with a C345C knob-proximal region of the C3c moiety of iC3b.

Dimerization of the αMβ2 Headpiece.

When incubated alone in buffer with 1 mM Mn2+ and 0.2 mM Ca2+, the αMβ2 headpiece readily formed a dimer, as shown both by gel filtration (Fig. 3 AC) and EM (Fig. 3E and Fig. S3 B and C). Dimer formation was not seen in buffer with 1 mM Mg2+ and 1 mM Ca2+ (Fig. 3C). When the αMβ2 headpiece and iC3b were mixed in buffer with 1 mM Mn2+ and 0.2 mM Ca2+, αMβ2 complex formation with iC3b was favored over αMβ2 dimer formation, with only 1 of 50 class averages showing the dimer (Fig. S3A). Dimer formation appears to reflect the ability of αMβ2 to promiscuously recognize a wide range of ligands (Introduction). αMβ2 headpiece dimers displayed dyad symmetry, with the αI domain of one monomer bound to the distal end of the β-leg, i.e., to the I-EGF1 or PSI domain, of the other monomer (Fig. 3E, see diagram below). Furthermore, cross-correlation showed that the headpiece was open when one αMβ2 monomer bound to another monomer (Fig. 3E).

Discussion

Recognition of the complement degradation product iC3b by leukocyte integrins αXβ2 and αMβ2 is critical for phagocytosis of opsonized foreign particles in host defense. The αX and αM subunits are 60% identical in sequence overall, and their αI domains have 57% sequence identity. Based on sequence homology and recognition of the same ligand, it might be expected that αXβ2 and αMβ2 would bind similarly to iC3b (19). Here, using negative-stain EM, we clearly show that αXβ2 and αMβ2 bind to distinct sites on iC3b.

Structures of the αXβ2 and αMβ2 αI domains, including the αX αI domain trapped in the open conformation by a lattice contact in bent αXβ2 ectodomain crystals (30), and of the open αM αI domain bound to the C3 TED (21) show marked differences that rationalize their differences in specificity. Residues in the αM αI domain that contact the TED, which lie in loops that surround the MIDAS Mg2+ ion, differ completely in αX. Thus, the most important TED-contacting residues in αM, with the equivalent αX residues in parenthesis, are Glu-178 (Asn), Glu-179 (Lys), Leu-206 (Gln), Arg-208 (Phe), and Phe-246 (Glu). The differences in side-chain structure, charge, and hydrophobicity are major and readily explain why αXβ2 and αMβ2 bind to different regions of iC3b.

Our studies on αXβ2 here extended a previous EM study on the αXβ2 ectodomain (19) by using the isolated αI domain and by identifying the location of a secondary binding site in iC3b. The isolated αI domain bound near the interface of the MG3 and MG4 domains in iC3b and C3c and less frequently to an additional, secondary site near the C345C knob in C3c. We were able to confirm binding to the secondary site by using the intact αXβ2 ectodomain in both iC3b and C3c. Although we did not observe the secondary site using the αI domain with iC3b, the technical limitations of multivariate K-means classification may have been responsible for a failure to resolve both variation among particles in position of the TED and variation in whether a second αI domain was bound in class averages. The TED is larger than the αI domain and, thus, more dominant in K-means classification. We previously experienced similar dominance of the αXβ2 ectodomain over the TED: In αXβ2 complexes with iC3b, the TED was not resolved, whereas averaging iC3b particles in the same fields that were not bound to αXβ2 resolved the TED (19).

The secondary binding site near the C345C knob resolved here both with binding of the αX αI domain to C3c and binding of the αXβ2 ectodomain to iC3b and C3c is adjacent to the CUB domain linkage to the MG key ring. This region becomes exposed when the CUB domain is cleaved in conversion of C3b to iC3b. Thus, the secondary binding site may be relevant in physiologic recognition of iC3b. Because αXβ2 recognizes negatively charged residues in proteolyzed or denatured proteins as a danger receptor (26), it is reasonable to ask whether negatively charged regions are near the secondary recognition site. One candidate is the cleaved terminus of the CUB domain that precedes the MG8 domain, which is present in both iC3b and C3c. The terminal sequence is SEETKENEG and, thus, rich in acidic glutamic residues. Furthermore, this segment is disordered in the C3c crystal structure (31), consistent with recognition by αXβ2 of denatured proteins and the appearance of the αX αI domain on either side of the C345C knob in class averages. We found that two αXβ2 ectodomain molecules could simultaneously bind to the primary site near MG3 and MG4 and the secondary site near the C345C knob on a single iC3b molecule. The use of both sites may contribute to more avid recognition by αXβ2 (CR4) of iC3b.

In addition to our main focus here on iC3b recognition, our studies also provide insights into promiscuous recognition and headpiece opening by αMβ2. Ligand binding through the αI domain was associated with swing-out of the β-subunit hybrid domain as visualized by the open headpiece conformation in EM. Studies with Fabs to the β2 subunit that stabilize the open conformation show that they greatly increase affinity of αLβ2 for its ligand ICAM-1 and of αXβ2 for iC3b (32, 33). Here, the principle that headpiece opening is associated with the high-affinity state of the αI domain (Fig. 1B) has been extended to integrin αMβ2, and was demonstrated for both binding of αMβ2 to a specific ligand (iC3b) and a promiscuous ligand (αMβ2).

Specific and promiscuous recognition by αMβ2 are brought into focus here by its ability to both bind iC3b and self-associate into dimers. Integrin αMβ2 has been found to bind a range of ∼40 different proteins, glycans including heparin, and denatured proteins (reviewed in ref. 25). Nonetheless, αMβ2 (CR3) is highly selective for iC3b. αMβ2 on the surface of myelomonocytic cells selectively rosettes with cells sensitized with iC3b but not with cells bearing IgM, C3b, or C3d (4, 5). The latter is equivalent to the TED.

Our studies on αMβ2 show that it not only binds through its αI domain to the TED in iC3b, but also binds through its head region to the C345C-proximal region of the C3c moiety. The recent crystal structure of the αM αI domain bound to TED was validated with measurement of a micromolar KD value and elimination of binding with mutation of a key recognition residue in TED (21). However, because binding to TED (C3d) did not match the specificity of αMβ2 for iC3b, this study raised two possibilities: (i) Binding to TED might reflect the promiscuity of αMβ2 and not be related to iC3b recognition. (ii) As suggested by the authors, binding of the αI domain to TED might represent only one of two interactions, with the second interaction providing selectivity for iC3b over C3d. Although previous structural work on recognition by αMβ2 of iC3b was with the isolated αM αI domain, our current work is with the αMβ2 headpiece and provides evidence for such a second interaction.

In αMβ2 complexes with iC3b, despite the flexible linkage connecting the αI domain-bound TED to the C3c moiety through the unfolded, partially cleaved CUB domain, almost all class averages showed a similar orientation of the C3c moiety, with the thick side of the MG key ring facing the integrin and the C345C knob-proximal region of the C3c moiety touching or near to the β-propeller/βI domain portion of the αMβ2 head. An interaction in this region of iC3b with the β-propeller/βI domain region of αMβ2 is strongly suggested by the preponderance of class averages with this orientation and the contrast with the random orientation of the TED relative to C3c moiety in class averages of iC3b alone. Evidence for a specific interaction in this region is further strengthened by the uniform orientation of the αMβ2 headpiece with its β-subunit side proximal to the C3c moiety of iC3b. Because in iC3b the TED is flexibly tethered through the unfolded remnant of the CUB domain to the C3c moiety, TED flexibility should generate random orientations of the C3c moiety relative to the αMβ2 headpiece if there were no interactions other than those between the αI domain and TED. In summary, both the similar positions of the C3c moiety relative to the αMβ2 headpiece in all well-resolved class averages of the iC3b–αMβ2 headpiece complex, and the orientation with the thick side of the MG domain ring in C3c facing the headpiece and the β-subunit side of the headpiece facing the C3c moiety, support an additional stabilizing interaction between the C345C-proximal region of the C3c moiety and the β-propeller/βI domain portion of the αMβ2 head.

An interaction of the knob-proximal region of the MG domain ring of iC3b with the β-propeller/βI domain region of αMβ2 is consistent with previous evidence that these regions contribute to CR3 function. When the αI domain is deleted from αMβ2, it retains partial ability to bind iC3b but not several other ligands, and residual CR3 function is completely inhibited by an antibody to the β-propeller domain (22). The antibody binds an epitope that includes a βI domain-proximal loop in blade (β-sheet) 6 of the β-propeller domain (34, 35). Mutagenesis has suggested a role for nearby blade 4 of the β-propeller domain and the βI domain in iC3b recognition (23, 24). Moreover, the recognition site near the C345C knob on the MG key ring of the C3c moiety is consistent with previous mutational data on CR3 recognition of iC3b. Mutation of iC3b residues 736 and 737, which localize to the α′NT segment, markedly diminishes recognition of iC3b by αMβ2 (36). Notably, α′NT localizes to the thick side of the C3c key ring adjacent to the C345C knob (Fig. 1A), i.e., the same region of iC3b that we find interacts with the β-propeller/βI domain region of αMβ2. Taken together, the mutational and antibody inhibition data on integrin αMβ2, the mutational data on iC3b, and our EM data on αMβ2 complexes with iC3b support a model in which the specificity of αMβ2 for iC3b derives from bipartite binding of the αI domain and β-propeller/βI domain of αMβ2 to the TED and C3c moieties, respectively, of iC3b.

Interestingly, we were also able to compare here the selective interaction of αMβ2 with iC3b to a promiscuous self-association with αMβ2. Notably, αMβ2 self-associates in a reciprocal, symmetric interaction. Thus, the particular promiscuous interaction visualized here was favored by the greater avidity of a dimeric than a monomeric interaction. Despite the difference in avidity, when αMβ2 and iC3b were mixed together, recognition of iC3b predominated over self-association, consistent with the selectivity of αMβ2 for iC3b compared with other C3 fragments.

In summary, the direct comparisons here between αXβ2 (CR4) and αMβ2 (CR3) show that although these integrins are close relatives of one another, they bind to different sites on iC3b and, therefore, appear to have independently evolved their specificity for iC3b. There is extensive overlap in expression of these leukocyte integrins on cell types, with both expressed on macrophages and neutrophils, whereas αXβ2 is selectively expressed on dendritic cells (10, 11). Remarkably, the primary binding site of αXβ2 on the thin side of the C3c key ring lies distal from the αMβ2 binding site on the TED domain and thick side of the C3c key ring and comparison of class averages of αXβ2 and αMβ2 complexes with iC3b (Figs. 2 and 3) suggest that no overlap between the integrins would occur upon simultaneous binding to the same iC3b molecule. The recognition of independent sites by CR3 and CR4 on iC3b provides greater diversity in recognition of opsonized pathogens and immune complexes, and may also allow cooperative interactions between the two integrins.

Materials and Methods

Integrin αX αI Domain.

The αX αI domain (residues E130 to G319 with F273S and F300A mutations) was expressed in pET28a with a 6 His tag at the N terminus in Escherichia coli BL 21(DE3) cells. Expression was induced with 1 mM isopropyl β-d-thiogalactopyranoside for 24 h at 16 °C. Washed bacteria were sonicated in 50 mM Tris pH 8.0, 300 mM NaCl, 10% (vol/vol) glycerol, and 1 mM phenylmethanesulfonyl fluoride. Protein was purified with Ni-NTA resin (Qiagen) and then by gel filtration on a Superdex 200 10/300 column (GE Healthcare) in 20 mM Tris pH 8.0, 300 mM NaCl, 10% (vol/vol) glycerol.

Integrin αMβ2 Headpiece.

The cDNA encoding the mature residues 1–752 of αM was cloned into ET11 vector, which was derived from ET1 vector (34). The cDNA encoding the signal sequence and mature residues 1–460 of β2 subunit was cloned into pEF1-puro vector as described (37). HEK293 cells were cotransfected with expression constructs, and protein was expressed and purified as described (38).

Preparation of Complement iC3b and C3c.

Human C3 was purified as described (39). iC3b was prepared according to the literature (40) with slight modification. Generally, the C3 was digested by trypsin to generate C3b and then treated with Factor H/I to generate iC3b. Outdated human plasma (500 mL, stored for several weeks at 4 °C) was treated with 25 mg of zymosan (Complement Technology) for 5 d at 37 °C. C3c was purified by polyethylene glycol precipitation, anion exchange chromatography (DEAE Sephacel, GE Healthcare), cation exchange chromatography (SP fast flow Sepharose, GE Healthcare) and size-exclusion chromatography (Superdex 200 16/60, GE Healthcare) as described (31). C3c was finally stored in buffer containing 20 mM Tris pH 7.4, 150 mM NaCl, 2 mM MgCl2.

Negative-Stain EM.

Purified αX αI domain was mixed with iC3b or C3c at a molar ratio of 10:1 with MgCl2 brought to a final concentration of 2 mM. Complexes were purified by using a Superdex 200 10/300 column (GE Healthcare) in 20 mM Hepes pH 7.4, 150 mM NaCl, and 2 mM MgCl2. The αMβ2 headpiece was mixed with iC3b or C3c at a molar ratio of 1:4 in presence of 1 mM MnCl2 and 0.2 mM CaCl2. Complexes were purified with Superdex 200 chromatography, 20 mM Hepes pH 7.4, 150 mM NaCl, 1 mM MnCl2, and 0.2 mM CaCl2. Peak fractions were adsorbed to glow-discharged carbon-coated copper grids, washed with deionized water, and stained with freshly prepared 0.75% uranyl formate. Low-dose images were acquired with an FEI Tecnai-12 transmission electron microscope at 120 kV and a nominal magnification of 67,000× or a Tecnai G2 Spirit BioTWIN transmission electron microscope at 80 kV and a nominal magnification of 68,000×. Image processing was performed with SPIDER and EMAN as described (19). Five thousand to seven thousand particles were picked interactively and subjected to multireference alignment and K-means classification specifying 50 classes. Cross-correlation was as described (19). The projection of open αMβ2 headpiece was generated by using a modeled open form αxβ2 headpiece, which contains αx from ref. 30 and open β from ref. 41.

Acknowledgments

This work was supported by NIH Grants HL103526 (to J.-H.W.) and AI72765 (to T.A.S.).

Footnotes

The authors declare no conflict of interest.

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1620881114/-/DCSupplemental.

References

  • 1.Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344(14):1058–1066. doi: 10.1056/NEJM200104053441406. [DOI] [PubMed] [Google Scholar]
  • 2.Berger M, Gaither IA, Frank MM. Complement receptors. Clin Immunol Rev. 1981-1982;1(4):471–545. [PubMed] [Google Scholar]
  • 3.Law SK, Dodds AW. The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci. 1997;6(2):263–274. doi: 10.1002/pro.5560060201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Beller DI, Springer TA, Schreiber RD. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J Exp Med. 1982;156(4):1000–1009. doi: 10.1084/jem.156.4.1000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ross GD, et al. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin. J Exp Med. 1983;158(2):334–352. doi: 10.1084/jem.158.2.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bilsland CAG, Diamond MS, Springer TA. The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b. Activation by a heterologous β subunit and localization of a ligand recognition site to the I domain. J Immunol. 1994;152(9):4582–4589. [PubMed] [Google Scholar]
  • 7.Micklem KJ, Sim RB. Isolation of complement-fragment-iC3b-binding proteins by affinity chromatography. The identification of p150,95 as an iC3b-binding protein. Biochem J. 1985;231(1):233–236. doi: 10.1042/bj2310233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lin Z, et al. Complement C3dg-mediated erythrophagocytosis: Implications for paroxysmal nocturnal hemoglobinuria. Blood. 2015;126(7):891–894. doi: 10.1182/blood-2015-02-625871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Inada S, et al. C3d receptors are expressed on human monocytes after in vitro cultivation. Proc Natl Acad Sci USA. 1983;80(8):2351–2355. doi: 10.1073/pnas.80.8.2351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Luk J, Luther E, Diamond MS, Springer TA. Subunit specificity and epitope mapping of Mac-1 and p150,95 mAb using chimeric CD11b x CD11c transfectants. In: Schlossman SF, et al., editors. Leucocyte Typing V: White Cell Differentiation Antigens. Oxford Univ Press; New York: 1995. pp. 1599–1601. [Google Scholar]
  • 11.Luk J, Springer TA. CD11b cluster report. In: Schlossman SF, et al., editors. Leucocyte Typing V: White Cell Differentiation Antigens. Oxford Univ Press; New York: 1995. pp. 1588–1590. [Google Scholar]
  • 12.Gahmberg CG, Tolvanen M, Kotovuori P. Leukocyte adhesion--structure and function of human leukocyte beta2-integrins and their cellular ligands. Eur J Biochem. 1997;245(2):215–232. doi: 10.1111/j.1432-1033.1997.00215.x. [DOI] [PubMed] [Google Scholar]
  • 13.Dupuy AG, Caron E. Integrin-dependent phagocytosis: Spreading from microadhesion to new concepts. J Cell Sci. 2008;121(11):1773–1783. doi: 10.1242/jcs.018036. [DOI] [PubMed] [Google Scholar]
  • 14.Anderson DC, Springer TA. Leukocyte adhesion deficiency: An inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med. 1987;38:175–194. doi: 10.1146/annurev.me.38.020187.001135. [DOI] [PubMed] [Google Scholar]
  • 15.Tang T, et al. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J Exp Med. 1997;186(11):1853–1863. doi: 10.1084/jem.186.11.1853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Springer TA, Dustin ML. Integrin inside-out signaling and the immunological synapse. Curr Opin Cell Biol. 2012;24(1):107–115. doi: 10.1016/j.ceb.2011.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol. 1993;120(4):1031–1043. doi: 10.1083/jcb.120.4.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Michishita M, Videm V, Arnaout MA. A novel divalent cation-binding site in the A domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell. 1993;72(6):857–867. doi: 10.1016/0092-8674(93)90575-b. [DOI] [PubMed] [Google Scholar]
  • 19.Chen X, Yu Y, Mi LZ, Walz T, Springer TA. Molecular basis for complement recognition by integrin αXβ2. Proc Natl Acad Sci USA. 2012;109(12):4586–4591. doi: 10.1073/pnas.1202051109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Vorup-Jensen T. Surface plasmon resonance biosensing in studies of the binding between β2 integrin I domains and their ligands. Methods Mol Biol. 2012;757:55–71. doi: 10.1007/978-1-61779-166-6_5. [DOI] [PubMed] [Google Scholar]
  • 21.Bajic G, Yatime L, Sim RB, Vorup-Jensen T, Andersen GR. Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3. Proc Natl Acad Sci USA. 2013;110(41):16426–16431. doi: 10.1073/pnas.1311261110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yalamanchili P, Lu C, Oxvig C, Springer TA. Folding and function of I domain-deleted Mac-1 and lymphocyte function-associated antigen-1. J Biol Chem. 2000;275(29):21877–21882. doi: 10.1074/jbc.M908868199. [DOI] [PubMed] [Google Scholar]
  • 23.Xiong YM, Haas TA, Zhang L. Identification of functional segments within the β2I-domain of integrin αMβ2. J Biol Chem. 2002;277(48):46639–46644. doi: 10.1074/jbc.M207971200. [DOI] [PubMed] [Google Scholar]
  • 24.Li Y, Zhang L. The fourth blade within the β-propeller is involved specifically in C3bi recognition by integrin α M β 2. J Biol Chem. 2003;278(36):34395–34402. doi: 10.1074/jbc.M304190200. [DOI] [PubMed] [Google Scholar]
  • 25.Podolnikova NP, Podolnikov AV, Haas TA, Lishko VK, Ugarova TP. Ligand recognition specificity of leukocyte integrin αMβ2 (Mac-1, CD11b/CD18) and its functional consequences. Biochemistry. 2015;54(6):1408–1420. doi: 10.1021/bi5013782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Vorup-Jensen T, et al. Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin αXβ2. Proc Natl Acad Sci USA. 2005;102(5):1614–1619. doi: 10.1073/pnas.0409057102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Lee J-O, Rieu P, Arnaout MA, Liddington R. Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18) Cell. 1995;80(4):631–638. doi: 10.1016/0092-8674(95)90517-0. [DOI] [PubMed] [Google Scholar]
  • 28.Jin M, et al. Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinity. Proc Natl Acad Sci USA. 2006;103(15):5758–5763. doi: 10.1073/pnas.0601164103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Nishida N, Walz T, Springer TA. Structural transitions of complement component C3 and its activation products. Proc Natl Acad Sci USA. 2006;103(52):19737–19742. doi: 10.1073/pnas.0609791104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Sen M, Yuki K, Springer TA. An internal ligand-bound, metastable state of a leukocyte integrin, αXβ2. J Cell Biol. 2013;203(4):629–642. doi: 10.1083/jcb.201308083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Janssen BJ, et al. Structures of complement component C3 provide insights into the function and evolution of immunity. Nature. 2005;437(7058):505–511. doi: 10.1038/nature04005. [DOI] [PubMed] [Google Scholar]
  • 32.Schürpf T, Springer TA. Regulation of integrin affinity on cell surfaces. EMBO J. 2011;30(23):4712–4727. doi: 10.1038/emboj.2011.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Chen X, et al. Requirement of open headpiece conformation for activation of leukocyte integrin αXβ2. Proc Natl Acad Sci USA. 2010;107(33):14727–14732. doi: 10.1073/pnas.1008663107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sen M, Springer TA. Leukocyte integrin αLβ2 headpiece structures: The αI domain, the pocket for the internal ligand, and concerted movements of its loops. Proc Natl Acad Sci USA. 2016;113(11):2940–2945. doi: 10.1073/pnas.1601379113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lu C, Oxvig C, Springer TA. The structure of the β-propeller domain and C-terminal region of the integrin αM subunit. Dependence on β subunit association and prediction of domains. J Biol Chem. 1998;273(24):15138–15147. doi: 10.1074/jbc.273.24.15138. [DOI] [PubMed] [Google Scholar]
  • 36.Taniguchi-Sidle A, Isenman DE. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha’-chain. J Immunol. 1994;153(11):5285–5302. [PubMed] [Google Scholar]
  • 37.Nishida N, et al. Activation of leukocyte β2 integrins by conversion from bent to extended conformations. Immunity. 2006;25(4):583–594. doi: 10.1016/j.immuni.2006.07.016. [DOI] [PubMed] [Google Scholar]
  • 38.Dong X, Hudson NE, Lu C, Springer TA. Structural determinants of integrin β-subunit specificity for latent TGF-β. Nat Struct Mol Biol. 2014;21(12):1091–1096. doi: 10.1038/nsmb.2905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Sottrup-Jensen L, Andersen GR. Purification of human complement protein C5. Methods Mol Biol. 2014;1100:93–102. doi: 10.1007/978-1-62703-724-2_7. [DOI] [PubMed] [Google Scholar]
  • 40.Alcorlo M, et al. Unique structure of iC3b resolved at a resolution of 24 Å by 3D-electron microscopy. Proc Natl Acad Sci USA. 2011;108(32):13236–13240. doi: 10.1073/pnas.1106746108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature. 2004;432(7013):59–67. doi: 10.1038/nature02976. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES